Pure Global AI
NCT06047626Not yet recruiting

Living Well With Lymphoma

Living Well With Lymphoma: Improving Diet Quality to Improve Energy, Sleep and Quality of Life
University of Michigan Rogel Cancer CenterClinicalTrials.govother
Verified
Study focus
Disease/Condition
Lymphoma
Drug/Device/Intervention
Fatigue Reduction Diet
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Michigan Rogel Cancer Center
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Apr 01, 2028
Enrollment
68 participants
Primary outcome

Brief Fatigue Inventory

Summary

In this study the investigators are proposing to evaluate the efficacy, sustainability, and
 mechanisms of 3 months of individualized counseling of the FRD delivered by registered
 dietitians, over 8 sessions by phone/video conferencing on fatigue, quality of life, and
 associated symptoms in persistently fatigued lymphoma cancer survivors compared to 3 months
 of individualized counseling of the attention control (matched for time and frequency of
 interactions with the FRD) the General Health Curriculum (GHC). The investigators will
 randomize and follow 68 lymphoma cancer survivors; accounting for a ~10% drop out rate to
 achieve a target of 60 patients that will complete the study. The investigators hypothesize
 that persistently fatigued lymphoma cancer survivors will experience improvements in fatigue,
 quality of life, and symptoms commonly associated with fatigue, which are then maintained at
 15-months post-enrollment; and decreased CRP and alterations in inflammation-associated DNA
 methylation consistent with reduced inflammation from following the FRD as compared to the
 GHC.

ICD-10 classifications
Hodgkin lymphomaFollicular lymphomaNon-Hodgkin lymphoma, unspecifiedFollicular lymphoma, unspecifiedHodgkin lymphoma, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06047626
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06047626 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan Rogel Cancer Center and is currently Not yet recruiting. The study focuses on Lymphoma. Target enrollment is 68 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.